Sanguina, Inc.
PrivateLast Round
Grant
Sep 14, 2023
Total Funding Raised
$5.85M
Company Overview
Sanguina, Inc. is a healthtech company that provides point-of-care diagnostics products, including at-home tests and digital tools, for anemia screening and blood health management.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Computer Vision, Healthcare Analytics, Patient Engagement
Business Model
B2C
Customer Profile
Subscription SaaS, Freemium, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sanguina, Inc. Comparables
Compare Sanguina, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Monere | 81% | |
| HemaChrome | 79% | |
| Masimo Corporation | 61% | |
Sanguina, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 14, 2023 | ||||
| Series A | Jul 25, 2023 | ||||
| Seed | Dec 8, 2020 | ||||
| Grant | Feb 26, 2019 |
Key People
Founding team and executive leadership
Sanguina, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| XRC Labs | Seed |
| The Seed Lab | Series A, Seed |
| Veritus Holdings | Series A |
| National Institutes of Health (NIH) | Grant |
| National Science Foundation | Grant |
| Veritus Holdings | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 31, 2025
Named Grand Prize Winner in the RADx Maternal Health Challenge.
- Sep 14, 2023
$525K grant received from the National Institutes of Health.
Sanguina, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Sanguina, Inc.'s valuation, stock price, and market status.